×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ALPA LABORATORIES LTD. | 310.69 | 117.76 | 191.11 | 5.6 | 200.0 | 7.63 |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 198 | 47.7 |
| Aashka Hospitals Limited | NA | NA | NA | NA | 194 | 82.7 |
Alpa Laboratories Limited, with Security Code 532878, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.2 | 25.4 | 32.4 | 27.3 | 23.6 | 21.4 | 24.9 | 26.2 | 39.1 | 19.1 |
| Expenses | 19.9 | 26.6 | 29.1 | 24.8 | 20.1 | 20.9 | 21.7 | 25.4 | 39.5 | 18.7 |
| Operating Profit | 9.3 | -1.1 | 3.3 | 2.5 | 3.5 | 0.5 | 3.3 | 0.7 | -0.4 | 0.4 |
| OPM % | 31.74% | -4.51% | 10.23% | 9.01% | 14.9% | 2.53% | 13.12% | 2.84% | -0.91% | 2.22% |
| Other Income | -0.8 | 4.5 | 3.0 | 3.6 | 4.0 | 5.2 | 6.9 | 8.8 | 3.2 | 12.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 |
| Profit before tax | 7.9 | 3.0 | 5.7 | 5.3 | 6.6 | 5.1 | 9.6 | 8.9 | 2.3 | 11.8 |
| Tax % | -41.7% | 0% | 0% | -14.8% | -46.7% | 0% | -20.5% | 0% | -182.2% | 0% |
| Net Profit | 4.6 | 3.0 | 5.7 | 4.5 | 3.5 | 5.1 | 7.6 | 8.9 | -1.9 | 11.8 |
| EPS in Rs | 2.09 | 1.44 | 2.75 | 2.15 | 1.7 | 2.44 | 3.63 | 4.24 | 0 | 5.6 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.3 | 29.2 | 25.4 | 32.4 | 27.3 | 23.6 | 21.4 | 24.9 | 26.2 | 39.9 |
| Expenses | 24.7 | 19.9 | 26.6 | 29.0 | 24.9 | 20.1 | 20.9 | 21.6 | 25.4 | 39.7 |
| Operating Profit | 2.6 | 9.2 | -1.1 | 3.4 | 2.4 | 3.5 | 0.5 | 3.3 | 0.7 | 0.2 |
| OPM % | 9.61% | 31.59% | -4.49% | 10.35% | 8.91% | 14.86% | 2.48% | 13.31% | 2.84% | 0.54% |
| Other Income | 2.7 | -0.7 | 4.5 | 3.0 | 3.6 | 4.0 | 5.2 | 6.9 | 8.8 | 2.5 |
| Interest | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 |
| Depreciation | 0.1 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 |
| Profit before tax | 5.1 | 8.0 | 3.0 | 5.8 | 5.3 | 6.7 | 5.1 | 9.7 | 8.9 | 2.1 |
| Tax % | 0% | -41.6% | 0% | 0% | -14.9% | -46.7% | 0% | 20.4% | -0% | -197.6% |
| Net Profit | 5.1 | 4.7 | 3.0 | 5.8 | 4.5 | 3.6 | 5.1 | 7.7 | 8.9 | -2.1 |
| EPS in Rs | 2.43 | 2.12 | 1.44 | 2.75 | 2.17 | 1.71 | 2.42 | 3.66 | 4.23 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 45% |
| 3 Years: | 49% |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 44% |
| 3 Years: | 15% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 82% |
| 3 Years: | 49% |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 44% |
| 3 Years: | 15% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|